MBX Biosciences, Inc 10-K for FY2025
MBX Biosciences, Inc. (MBX)
10-K
2026-03-12
For: 2025-12-31
View Original
Added on
April 10, 2026
About this 10-K
MBX Biosciences, Inc filed this 10-K on March 12, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $86.97M
- compared with a net loss of $61.92M a year earlier
- Diluted EPS
- -$2.38
- compared with -$5.82 a year earlier